HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip A Barber Selected Research

Philip A Barber Research Topics

Disease

19Stroke (Strokes)
10/2020 - 01/2002
10Ischemic Stroke
12/2020 - 01/2002
7Ischemia
12/2020 - 07/2004
6Infarction (Infarctions)
12/2020 - 05/2013
5Alzheimer Disease (Alzheimer's Disease)
01/2022 - 12/2015
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2015 - 01/2003
3Cognitive Dysfunction
01/2022 - 01/2018
3Atrophy
12/2021 - 01/2018
3Hypothermia
12/2015 - 01/2003
2Vascular Diseases (Vascular Disease)
08/2021 - 01/2018
2Edema (Dropsy)
01/2020 - 01/2012
2Brain Ischemia (Cerebral Ischemia)
01/2012 - 02/2010
1Disease Progression
12/2021
1Gliosis
12/2021
1Sudden Hearing Loss (Sudden Deafness)
11/2021
1Myocardial Infarction
10/2020
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2018
1Transient Ischemic Attack
01/2018
1Brain Infarction
03/2016
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
12/2015
1Intracranial Hemorrhages (Intracranial Hemorrhage)
03/2015
1Leukoaraiosis
01/2008
1Hemorrhage
01/2007
1Diabetes Complications
08/2006

Drug/Important Bio-Agent (IBA)

6Tissue Plasminogen Activator (Alteplase)FDA Link
03/2016 - 01/2002
4Amyloid (Amyloid Fibrils)IBA
01/2022 - 12/2015
3Gadolinium DTPA (Magnevist)FDA Link
09/2011 - 07/2004
2Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2012
2Neuroprotective AgentsIBA
01/2020 - 05/2013
2Biomarkers (Surrogate Marker)IBA
12/2018 - 01/2018
2Immunoglobulin G (IgG)IBA
12/2015 - 02/2010
2ResveratrolIBA
05/2013 - 01/2012
2PolyphenolsIBA
05/2013 - 01/2012
2salicylhydroxamic acid (SHAM)IBA
06/2012 - 11/2005
2Glucose (Dextrose)FDA LinkGeneric
01/2012 - 01/2007
2Contrast MediaIBA
02/2010 - 07/2004
1Formaldehyde (Formol)FDA Link
01/2022
1Protein AggregatesIBA
12/2021
1IronIBA
01/2018
1Biological ProductsIBA
03/2016
1Flavin-Adenine Dinucleotide (FAD)IBA
12/2015
1FibrinIBA
03/2015
1Fibrinolytic Agents (Antithrombotic Agents)IBA
03/2015
1Pharmaceutical PreparationsIBA
03/2015
1TenecteplaseFDA Link
03/2015
1Adenosine Triphosphate (ATP)IBA
05/2013
1NAD (NADH)IBA
05/2013
1Sirtuin 1IBA
05/2013
1Matrix Metalloproteinases (MMPs)IBA
06/2012
1Oxygen (Dioxygen)IBA
01/2012
1Acetic Acid (Vinegar)FDA LinkGeneric
09/2011
1Claudin-5IBA
09/2011
1OccludinIBA
09/2011
1diethylenetriamineIBA
09/2011
1PENTAIBA
09/2011
1GadoliniumIBA
09/2011
1P-SelectinIBA
02/2010
1Fluorescein-5-isothiocyanate (FITC)IBA
02/2010
1Receptor for Advanced Glycation End ProductsIBA
08/2006
1E-SelectinIBA
07/2004
1Sialyl Lewis X AntigenIBA
07/2004

Therapy/Procedure

13Therapeutics
12/2020 - 01/2002
2Secondary Prevention
08/2021 - 01/2018
1Thrombectomy
11/2021
1Aftercare (After-Treatment)
12/2016
1Time-to-Treatment
12/2015
1Rewarming
12/2015
1Length of Stay
01/2009
1Thrombolytic Therapy
02/2004
1Decompression
01/2003